A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study Evaluating the Efficacy and Safety of 18 Months Treatment with PF-04494700 in Participants with Mild-to-Moderate AD (RAGE)

Filter
Finished

Search results